New molecular targets for personalized treatment for Low-Grade Non-Hodgkin Lymphoma

403
Total downloads
2,959
Total views and downloads

Articles

REVIEW

Accepted on 23 Jun 2025

The Therapeutic Perspective of Relapsed/Refractory Waldenström Macroglobulinemia: What Comes Next?

Nicolò Danesin
Giovanni Leone
Mattia D'antiga
Marco Carraro
Greta Scapinello
LIVIO TRENTIN
Francesco Piazza

doi 10.3389/frhem.2025.1624046

ORIGINAL RESEARCH

Published on 16 Apr 2025

Dual targeting of EZH2 and PD-L1 in Burkitt’s lymphoma enhances immune activation and induces apoptotic pathway

Yurim Jeong
Hyewon Jang
Se Been Kim
Minseo Yu
Ra Eun Kim
Wan-Su Choi
Youngwoo Jeon
Jung-Yeon Lim

doi 10.3389/fimmu.2025.1578665

1,568 views

Share on

Frontiers in Hematology

Frontiers in Hematology

Blood Cancer

Participating Journals

Frontiers in Oncology
- Hematologic Malignancies
- 3.3 impact factor
- 6.9 citescore

Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.

Impact

2,959Topic views
1,496Article views
403Article downloads